| Literature DB >> 35388780 |
Semiha Aydin1, Bart M Siebelink2, Matty R Crone3, Joost R van Ginkel4, Mattijs E Numans3, Robert R J M Vermeiren5, P Michiel Westenberg6.
Abstract
BACKGROUND: A variety of information sources are used in the best-evidence diagnostic procedure in child and adolescent mental healthcare, including evaluation by referrers and structured assessment questionnaires for parents. However, the incremental value of these information sources is still poorly examined. AIMS: To quantify the added and unique predictive value of referral letters, screening, multi-informant assessment and clinicians' remote evaluations in predicting mental health disorders.Entities:
Keywords: Evidence-based assessment; diagnostic decision making; primary care; psychological testing; secondary mental healthcare
Year: 2022 PMID: 35388780 PMCID: PMC9059622 DOI: 10.1192/bjo.2022.47
Source DB: PubMed Journal: BJPsych Open ISSN: 2056-4724
Sample characteristics (N = 1259)
| Age, years | |
| 5–9 | 474 (37.6) |
| 10–14 | 508 (40.4) |
| 15–18 | 277 (22.0) |
| Gender | |
| Male | 723 (57.4) |
| Female | 536 (42.6) |
| CGAS | |
| 20–40 | 83 (6.6) |
| 41–50 | 503 (40.0) |
| 51–60 | 514 (40.8) |
| >61 | 96 (7.6) |
| Missing | 63 (5.0) |
| Medical conditions | |
| None classified | 958 (76.1) |
| Singular | 99 (7.9) |
| Complex | 52 (4.1) |
| Missing | 150 (11.9) |
| Number of clinical classifications (comorbidity) | |
| 0 | 175 (13.9) |
| 1 | 544 (43.2) |
| 2 | 368 (29.2) |
| 3 | 125 (9.9) |
| 4 | 35 (2.8) |
| 5–6 | 12 (1.0) |
| Type of clinical classifications | |
| Neurodevelopmental disorders | 727 (57.7) |
| Schizophrenia spectrum and other psychotic disorders | 2 (0.2) |
| Depressive disorders | 134 (10.6) |
| Anxiety disorders | 174 (13.8) |
| Obsessive–compulsive and related disorders | 13 (1.0) |
| Trauma and stressor-related disorders | 68 (5.4) |
| Somatic symptom and related disorders | 42 (3.3) |
| Feeding and eating disorders | 54 (4.3) |
| Elimination disorders | 19 (1.5) |
| Gender dysphoria | 7 (0.6) |
| Disruptive, impulse-control and conduct disorders | 71 (5.6) |
| Substance-related and addictive disorders | 2 (0.2) |
| Personality disorders | 49 (3.9) |
Distributions of the clinical classifications in the sample are depicted based on the higher-order chapters of the DSM-5 (e.g. ‘Neurodevelopmental disorders’). The number of clinical classifications is depicted on the level of the specific classifications (e.g. attention-deficit hyperactivity disorder and autism spectrum disorders). CGAS, Children's Global Assessment Scale score.
Two-by-two cross-tabulation of the instruments per disorder group
| Anxiety disorders | Depressive disorders | ASD | ADHD | Behavioural disorders | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| + | − | + | − | + | − | + | − | + | − | ||
| Referral letters | 38 (46.9) | 81 (14.1) | 39 (60.0) | 73 (12.4) | 108 (54.8) | 89 (45.2) | 114 (55.9) | 99 (22.0) | 26 (59.1) | 156 (25.5) | |
| − | 43 (53.1) | 492 (85.9) | 26 (40.0) | 516 (87.6) | 89 (45.2) | 361 (80.2) | 90 (44.1) | 350 (78.0) | 18 (40.9) | 455 (74.5) | |
| SDQ | 77 (95.1) | 442 (77.1) | 62 (95.4) | 457 (77.6) | 140 (71.1) | 204 (45.3) | 181 (88.7) | 230 (51.2) | 38 (86.4) | 328 (53.7) | |
| − | 4 (4.9) | 131 (22.9) | 3 (4.6) | 132 (22.4) | 57 (28.9) | 246 (54.7) | 23(11.3) | 219 (48.8) | 6 (13.6) | 283 (46.3) | |
| DAWBA band | 57 (70.4) | 185 (32.2) | 45 (69.2) | 94 (16.0) | 18 (9.1) | 5 (1.1) | 121 (59.3) | 78 (17.4) | 16 (36.4) | 225 (36.9) | |
| − | 24 (29.6) | 388 (67.7) | 20 (30.8) | 495 (84.0) | 179 (90.9) | 445 (98.9) | 83 (40.7) | 371 (82.6) | 28 (63.6) | 384 (63.1) | |
| Clinician-rated DAWBA | 62 (76.5) | 194 (33.9) | 49 (75.4) | 104 (17.7) | 151 (76.6) | 154 (34.2) | 170 (83.3) | 158 (35.2) | 26 (59.1) | 200 (32.7) | |
| − | 19 (23.5) | 379 (66.1) | 16 (24.6) | 485 (82.3) | 46 (23.4) | 296 (65.8) | 34 (16.7) | 291 (64.8) | 18 (40.9) | 411 (67.3) | |
Frequency (%) of the positive and negative indications made per instrument and per disorder group, as a ratio of the total number of positive and negative cases. Number of diagnoses and sample size were as follows: anxiety disorders n = 81 and N = 654; depressive disorder n = 65 and N = 654, ASD n = 197 and N = 647; ADHD n = 204 and N = 653; behavioural disorders n = 44 and N = 655. ASD, autism spectrum disorders; ADHD, attention-deficit hyperactivity disorder; SDQ, Strengths and Difficulties Questionnaire; DAWBA band, Development and Well-Being Assessment probability band score.
Likelihood ratio test values comparing the effect of addition of instruments on model fit per disorder group
| Referral letters | +SDQ | +DAWBA band | +Clinician-rated DAWBA | |
|---|---|---|---|---|
| Anxiety disorders | 92.74 | 33.47 | 41.81 | 15.1 |
| Depressive disorders | 136.81 | 8.28* | 39.63 | 17.48 |
| ASD | 166.29 | 44.48 | 15.25 | 14.50 |
| ADHD | 203.53 | 79.52 | 42.23 | 39.58 |
| Behavioural disorders | 44.26 | 16.04 | 16.78 | 0.02** |
Likelihood ratio test results depicting change in model fit by successive addition of the instruments, computed in the imputed data-set. All values are significant at the P < 0.001 level, except *P = 0.004 and **P = 0.82. Note the low frequency of four successive positive indications for ASD and ADHD, as it was uncommon for these minors to have positive scores on all four instruments. SDQ, Strengths and Difficulties Questionnaire; DAWBA band, Development and Well-Being Assessment probability band score; ASD, autism spectrum disorders; ADHD, attention-deficit hyperactivity disorder.
Fig. 1Univariable and multivariable odds ratios per instrument and per diagnostic outcome. Odds ratios per instrument and per disorder group for four models, computed in the imputed data-set. Each successive model contains one more instrument as a predictor, presenting how the odds ratios change when controlling for overlap with more instruments. The vertical line presents an odds ratio equal to 1. DAWBA band refers to the DAWBA probability band score. ADHD, attention-deficit hyperactivity disorder; ASD, autism spectrum disorder; DAWBA, Development and Well-Being Assessment; SDQ, Strengths and Difficulties Questionnaire.